USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: 3DT HOLDINGS, LLC
Address: 251 N. Illinois Street
INDIANAPOLIS, IN 46204-
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $765,184.00 4

Award List:

Gastric Sleeve Magnetic Implant

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jose Navia
Award Amount: $99,936.00
Abstract:
DESCRIPTION (provided by applicant): The occurrence of obesity is increasingly growing, and it has been projected that 40% of the US population will be obese by the year 2025. The World Health Organization estimates over 1.6 billion adults (age 15+) are ov erweight, and at least 400 million are… More

Multi-Functional Guidewire for Peripheral Vasculature

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: William Combs – 317-377-0300
Award Amount: $199,756.00
Abstract:
DESCRIPTION (provided by applicant): Over 8 million Americans have peripheral vascular disease (PAD). Percutaneous transluminal artery (PTA) treatment of severe PAD involves the use of balloons and stents, but delivery of these therapies is often suboptimal due to inaccuracies in angiographic… More

Portable device for monitoring water balance in elderly

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mark C. Svendsen – 317-377-0300
Award Amount: $269,255.00
Abstract:
DESCRIPTION (provided by applicant): Transseptal (TS) access for left heart procedures is an important and rapidly growing space for diagnostics and therapy delivery with an expected total of over 10 million U.S. patients. In the U.S. and/or Europe, TS access procedures are used for atrial… More

A mechanism-based computational tool to optimize pulmonary drug delivery

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mark C. Svendsen – 317-377-0300
Award Amount: $196,237.00
Abstract:
DESCRIPTION (provided by applicant): Coronary artery disease (CAD) is a national and worldwide epidemic that places the largest clinical and economic burden on the healthcare system of any disease condition. Patients with stable and acute coronary conditions are often treated with percutaneous… More